RecruitingNot ApplicableNCT05738005

Dietary Reporting in the Amyloidoses

DRITA Pilot Trial: Dietary Reporting in the Amyloidoses


Sponsor

Barbara Ann Karmanos Cancer Institute

Enrollment

40 participants

Start Date

Mar 2, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis. The main question it aims to answer is: Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients Participants will be asked to: * Download the MyFitnessPal application on their smartphone and view an online tutorial * After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone. * complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • years of age or older
  • Diagnosed with any type of amyloidosis
  • Speak, read and write in English
  • Willing to use the MyFitnessPal app on their own smartphone

Exclusion Criteria2

  • a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment
  • cognitive or perceptual disturbances

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)

Amyloidosis patients will use MyFitnessPal application to track dietary intake and use of herbal/alternative supplements in from week 2-9. Patient's usage of the application and questionnaires completed by the patient at the start, Week 2 and Week 10 will determine feasibility.


Locations(1)

Karmanos Cancer Institute

Detroit, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05738005


Related Trials